The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / FOCIS 2015: Metabolism May Affect Immune System’s Reaction to Disease

FOCIS 2015: Metabolism May Affect Immune System’s Reaction to Disease

October 13, 2015 • By Catherine Kolonko

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Carol and Mike Werner/sciencesource.com

Image Credit: Carol and Mike Werner/sciencesource.com

How the immune system reacts to potential harm, such as lack of oxygen and inflammation, depends greatly on the human body’s metabolic processes and pathways, according to speakers at FOCIS 2015 in San Diego this past June.

You Might Also Like
  • Insight into Crosstalk Between Bone & Immune Systems
  • FOCIS 2015: Key Protein Found to Control Trafficking of Toll-like Receptors
  • FOCIS 2015: TET Protein Regulation May Provide Insights for Cancer Treatment
Explore This Issue
October 2015

During a session devoted to metabolism and the immune system, researchers talked about recent studies that shed light on the body’s response to disease that could lead to a better understanding on prevention and treatment. The discussion began on a high-profile topic of chronic inflammation and a recent discovery of a key protein.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Calorie Restriction

The anti-inflammatory effects of consuming fewer calories appear to be linked to a compound molecule that can inhibit the inflammasome complex that drives some chronic diseases, said Vishwa Deep Dixit, PhD, a professor at Yale University School of Medicine, New Haven, Conn., during a discussion on how calorie restriction influences the immune system.

“When you calorie restrict animals, ranging from a worm all the way up to primates, it’s known that [doing so] substantially reduces the disease burden,” Dr. Dixit said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Dixit

Dr. Dixit

A compound called β-hydroxybutyrate (BHB) has been found to block the NLRP3 inflammasome, he said. As part of a complex group of proteins, NLRP3 is responsible for triggering inflammation in immune cells.

Inflammation drives several chronic diseases, such as Alzheimer’s, atherosclerosis and gout. Dr. Dixit outlined studies conducted by Yale School of Medicine researchers that revealed that BHB suppresses activation of the NLRP3 inflammasome in response to the presence of urate crystals, adenosine triphosphate and lipotoxic fatty acids. Such conditions as calorie restriction, fasting and high-intensity exercise prompt the body to produce higher ketone metabolite levels of BHB. Starvation or consumption of a low-carbohydrate ketogenic diet also produces the metabolite, Dr. Dixit said.

Under starvation conditions, the body burns fat, which increases ketones that replace glucose as a source of energy to the brain and other parts of the body. However, Dr. Dixit said it is unknown how these and other metabolic fuels produced during energy deficits exactly influence the innate immune response.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

It has been recognized that a starkly reduced intake of calories or fasting tends to diminish inflammation. With this in mind, researchers studying mice and human immune cells looked at how macrophages react to ketone bodies induced by restriction of calories, Dr. Dixit said.

Results from the study showed that BHB blocked the NLRP3 inflammasome by blocking a central adaptor protein needed for inflammation to occur. The significance of the discovery of this compound is that it could be useful in treatments of many inflammatory-driven conditions and diseases, Dr. Dixit said in his closing remarks.

Role of T Cells

The immune system comes into play again when talking about metabolic pathways in cancer and the important job of memory T cells to fight off pathogens., professor of biological sciences at the University of California, San Diego, spoke of her lab’s research on T cell differentiation and immunological memory. Her discussion focused mostly on regulators of the killer T cell immune response.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Meeting Reports Tagged With: Clinical, Disease, Immune System, metabolism, outcome, patient careIssue: October 2015

You Might Also Like:
  • Insight into Crosstalk Between Bone & Immune Systems
  • FOCIS 2015: Key Protein Found to Control Trafficking of Toll-like Receptors
  • FOCIS 2015: TET Protein Regulation May Provide Insights for Cancer Treatment
  • FOCIS 2015: Research Increases Understanding of Lupus, RA

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.